AGM/EGMJun 3, 2026, 04:13 PM
InspireMD Stockholders Approve 66.7% Increase in Authorized Shares
AI Summary
InspireMD, Inc. held its 2026 annual meeting of stockholders, where an amendment to the Company's Amended and Restated Certificate of Incorporation was approved. This amendment increases the authorized number of common stock shares from 150,000,000 to 250,000,000. Additionally, stockholders re-elected Marvin Slosman, Raymond Cohen, and Dan Dearen to the board of directors and ratified Kesselman & Kesselman as the independent registered public accounting firm for the 2026 fiscal year.
Key Highlights
- Stockholders approved increasing authorized common stock from 150,000,000 to 250,000,000 shares.
- The share increase was approved with 31,577,297 votes For, 3,009,107 Against, and 44,944 Withheld.
- Marvin Slosman, Raymond Cohen, and Dan Dearen were re-elected as Class 3 directors.
- Marvin Slosman received 25,086,284 For votes for re-election.
- Kesselman & Kesselman was ratified as the independent registered public accounting firm for 2026 with 34,355,150 For votes.
- A quorum of 73.85% of outstanding shares was present at the Annual Meeting.
Price Impact
More from NSPR